Target intelligence / Profile preview

Living cell graft

Molecular classification
Other
01

Overview

A living cell graft is a therapeutic modality consisting of viable cells, often integrated into a scaffold or matrix, administered to a patient to restore, replace, or enhance biological functions. Unlike conventional molecular targets such as receptors or enzymes, a living cell graft acts as a complex biological unit that can integrate into the host, respond to physiological signals, and provide long-term therapeutic effects (Source: NIH - National Center for Biotechnology Information). These grafts are utilized across diverse medical fields, including hematology for hematopoietic stem cell transplants and dermatology for bioengineered skin substitutes used in chronic wound care (Source: FDA - Cellular & Gene Therapy Products). The mechanism of action typically involves the direct replacement of damaged tissue or the secretion of paracrine factors that promote endogenous healing and modulate immune responses (Source: Nature Reviews Drug Discovery). Because these grafts are living tissues, they pose unique clinical challenges, including the requirement for immunological compatibility and the risk of serious adverse events such as graft-versus-host disease or unintended cellular transformation (Source: PubMed - Journal of Clinical Investigation). Consequently, while highly effective for tissue regeneration, they require rigorous monitoring for viability, engraftment, and long-term safety.

Other names
Cellular graftCell therapy productTissue-engineered graftCellular transplantLiving cell therapy
02

Mechanism of action

Direct replacement of damaged or dysfunctional host cells, integration into host tissue to restore structural integrity, or secretion of bioactive factors that stimulate endogenous repair and modulate immune activity.

03

Biological functions

Tissue regenerationImmune modulationCell replacementParacrine signalingEnzyme production
04

Disease associations

CancerHematologic malignancySevere burnsChronic woundsGenetic disordersDegenerative diseases
05

Safety considerations

Graft-versus-host disease (GVHD)Immune rejectionTumorigenicityCytokine release syndrome (CRS)Infection risk due to immunosuppressionEctopic tissue formation
06

Interacting drugs

Cyclosporine

5 more in the full profile.

07

Biomarkers

HLA matching (Human Leukocyte Antigen)Donor chimerismCell viabilityCD34+ cell countCytokine levels (e.g., IL-6 for CRS monitoring)

Beyond the preview

Go deeper on Living cell graft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Living cell graft.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call